Rayonier Advanced Materials reported a challenging fourth quarter with a net loss of $21 million and a slight decline in net sales to $417 million. The company is undergoing a strategic shift to focus on cash generation and disciplined execution following a year of volume and earnings pressure, aiming for positive free cash flow in 2026.
Net sales for Q4 2025 were $417 million, a slight decrease from $422 million in the prior year quarter.
Reported a net loss of $21 million ($0.32 per diluted share) compared to a $16 million loss in Q4 2024.
Adjusted EBITDA for the quarter was $46 million, down $5 million from the prior year period.
The company reorganized its High Purity Cellulose segment into three new businesses: Cellulose Specialties, Biomaterials, and Cellulose Commodities.
For 2026, RYAM is focusing on positive free cash flow, disciplined execution, and EBITDA improvement across all businesses.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance